title: Luteotropic effects of prostaglandin E2 on the human corpus luteum of the menstrual cycle and early pregnancy.
abstract: Human corpora lutea (CL) of the menstrual cycle and early pregnancy were excised at operation, cut into pieces, and incubated or superfused in the presence of hCG or prostaglandin (PG) E2. After incubation, the tissue levels of cAMP and the medium concentrations of progesterone (P) were determined, while the concentration of P was analyzed after superfusion. PGE2 stimulated cAMP formation in CL from all phases of the menstrual cycle as well as from early pregnancy and caused an increase in P formation in CL from the early and midluteal phases of the menstrual cycle as well as from early pregnancy. A difference was found in the latency, the lag phase until maximal response, and the duration of response between the effects of PGE2 and hCG on both cAMP and P formation. Thus, the effect of PGE2 started more rapidly and was of shorter duration than that of hCG. The stimulatory effect of PGE2 on CL from early pregnancy was of the same magnitude as that of CL from the menstrual cycle. On the other hand, hCG had less stimulatory effect on cAMP and P formation in CL from early pregnancy compared to CL from the menstrual cycle. We conclude that PGE2 stimulates P and cAMP formation in isolated human CL from all phases of the menstrual cycle as well as in early pregnancy, indicating a luteotropic effect of this PG.
authors.affiliation: Department of Obstetrics and Gynecology, University of Göteborg, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Hahlin
authors.forename: B
authors.initials: B
authors.lastname: Dennefors
authors.forename: C
authors.initials: C
authors.lastname: Johanson
authors.forename: L
authors.initials: L
authors.lastname: Hamberger
mesh_terms: D000328:Adult; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D003338:Corpus Luteum / Q000187:drug effects*; D000242:Cyclic AMP / Q000096:biosynthesis; D015232:Dinoprostone; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008875:Middle Aged; D011247:Pregnancy / Q000187:drug effects*; D011261:Pregnancy Trimester, First; D011374:Progesterone / Q000096:biosynthesis; D011458:Prostaglandins E / Q000494:pharmacology*; D013997:Time Factors
chemical_list: D006063:Chorionic Gonadotropin; D011458:Prostaglandins E; D011374:Progesterone; D000242:Cyclic AMP; D015232:Dinoprostone